Natco Pharma rises on launching Hepcinat LP in Nepal

28 Oct 2015 Evaluate

Natco Pharma is currently trading at Rs. 2582.00, up by 20.80 points or 0.81% from its previous closing of Rs. 2561.20 on the BSE.

The scrip opened at Rs. 2565.00 and has touched a high and low of Rs. 2607.30 and Rs. 2560.00 respectively. So far 3933 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2709.00 on 07-Apr-2015 and a 52 week low of Rs. 1301.90 on 17-Dec-2014.

Last one week high and low of the scrip stood at Rs. 2610.35 and Rs. 2525.50 respectively. The current market cap of the company is Rs. 8936.18 crore.

The promoters holding in the company stood at 51.29% while Institutions and Non-Institutions held 16.74% and 31.97% respectively.

Natco Pharma has launched the first licensed generic version of ledipasvir+sofosbuvir combination in Nepal, under its brand name Hepcinat LP. Ledipasvir+Sofosbuvir are a two-drug fixed-dose combination product that contains 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet and sold globally by Gilead Sciences Inc., under its brand HARVONI. It is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. The company priced its generic medicine, Hepcinat LP, at Rs 25,000/- for a bottle of 28 tablets in Nepal.

The company had signed a non-exclusive licensing agreement with Gilead Sciences earlier in 2015, to manufacture and sell generic versions of its chronic hepatitis C medicines, including generic version of HARVONI, in India and other 100 developing countries.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

 

Natco Pharma Share Price

898.80 -34.80 (-3.73%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×